The FDA has reported that Johnson & Johnson shut down a clinical trial of its antibiotic Doribax for a type of pneumonia after patients taking the drug had higher rates of death and a l... Read more
The Food and Drug Administration has declined to approve an expanded use of Doribax, a Johnson & Johnson antibiotic, despite an advisory panel’s favorable recommendation. That was... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.